Impact on affected families and society of severe rotavirus infections in Swedish children assessed in a prospective cohort study

References

• Parashar U, Hummelman E, Bresee J, et al. Global illness and deaths caused by rotavirus disease in children. Emerging Infect Dis. 2003;9:565–572.
   PubMed Web of Science ®Google Scholar
• Johansen K, Hedlund KO, Zweygberg-Wirgart B, et al. Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance. Scand J Infect Dis. 2008;40:958–964.
   PubMed Web of Science ®Google Scholar
• Johansen K, Bennet R, Bondesson K, et al. Incidence and estimates of the disease burden of rotavirus in Sweden. Acta Paediatr Suppl. 1999;88:20–23.
   PubMedGoogle Scholar
• Rinder M, Tran AN, Bennet R, et al. Burden of severe rotavirus disease leading to hospitalization assessed in a prospective cohort study in Sweden. Scand J Infect Dis. 2014;46:294–302.
   PubMed Web of Science ®Google Scholar
• Giaquinto C, van Damme P. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. Scand J Infect Dis. 2010;42:142–147.
   PubMed Web of Science ®Google Scholar
• Tran A, Bennet R, Cassel T, et al. Transmission of rotavirus to household members of Swedish children hospitalized for severe rotavirus gastroenteritis results in loss of parental productivity. 27th Annual Meeting of the European Society for Paediatric Infectious Diseases, ESPID Brussels, Belgium, June 9–13, 2009.
   Google Scholar
• Johansen K, Brytting M, Husberg M, et al. Estimates of healthcare and non-healthcare costs due to severe rotavirus infections leading to hospitalization in Swedish children (<5 years). 29th Annual Meeting of the European Society for Paediatrics Infectous Diseases, The Hague, 7–11, 2011.
   Google Scholar
• de Rougemont A, Kaplon J, Billaud G, et al. Sensitivity and specificity of the VIKIA Rota-Adeno immuno-chromatographic test (bioMérieux) and the ELISA IDEIA Rotavirus kit (Dako) compared to genotyping. Pathol Biol (Paris). 2009;57:86–89.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. SCB Utbildningsstatistisk årsbok. Available at http://www.scb.se/en_/ 2010
   Google Scholar
• Rappuoli R, Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature. 2011;473:463–469.
   PubMed Web of Science ®Google Scholar
• Bilcke J, Van Damme P, De Smet F, et al. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr. 2008;167:1409–1419.
   PubMed Web of Science ®Google Scholar
• Jit M, Edmunds WJ. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Vaccine. 2007;25:3971–3979.
   PubMed Web of Science ®Google Scholar
• Lorgelly PK, Joshi D, Gomara MI, et al. Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom (Structured abstract). Epidemiol Infect. 2008;136:44–55.
   PubMed Web of Science ®Google Scholar
• Aidelsburger P, Grabein K, Böhm K, et al. Cost-effectiveness of childhood rotavirus vaccination in Germany. Vaccine. 2014;32:1964–1974.
   PubMed Web of Science ®Google Scholar
• Goossens LM, Standaert B, Hartwig N, et al. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine. 2008;26:1118–1127.
   PubMed Web of Science ®Google Scholar
• Zomer TP, van Duynhoven YTHP, Mangen MJJ, et al. Assessing the introduction of universal rotavirus vaccination in the Netherlands. Vaccine. 2008;26:3757–3764.
   PubMed Web of Science ®Google Scholar
• Mangen MJ, Duynhoven YT, Vennema H, et al. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? (Structured abstract). Vaccine. 2010;28:2624–2635.
   PubMed Web of Science ®Google Scholar
• Giammanco MD, Coniglio MA, Pignato S, et al. An economic analysis of rotavirus vaccination in Italy (Structured abstract). Vaccine. 2009;27:3904–3911.
   PubMed Web of Science ®Google Scholar
• Tilson L, Jit M, Schmitz S, et al. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine. 2011;29:7463–7473.
   PubMed Web of Science ®Google Scholar
• Imaz I, Rubio B, Cornejo AM, et al. Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain. Prev Med. 2014;61:116–121.
   PubMed Web of Science ®Google Scholar
• Folkhälsomyndigheten. Hälsoekonomiskt kunskapsunderlag – Rotavirusvaccination En kostnadseffektivitetsanalys av ett införande av rotavirusvaccination i det svenska barnvaccinationsprogrammet. 2015.
   Google Scholar
• Jit M, Bilcke J, Mangen MJ, et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine. 2009;27:6121–6128.
   PubMed Web of Science ®Google Scholar
• Swedish National Agency for Education. Skolverket. Available from: https://www.skolverket.se/om-skolverket/andra-sprak/in-english.
   Google Scholar
• Giaquinto C, Van Damme P, Huet F, et al. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL study. J Infect Dis. 2007;195:S36–S44.
   PubMed Web of Science ®Google Scholar
• Senecal M, Brisson M, Lebel MH, et al. Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): a prospective community-based study. Can J Infect Dis Med Microbiol. 2008;19:397–404.
   PubMed Web of Science ®Google Scholar
• Marlow R, Finn A, Trotter C. Quality of life impacts from rotavirus gastroenteritis on children and their families in the UK. Vaccine. 2015;33:5212–5216.
   PubMed Web of Science ®Google Scholar
• Jacobs P, Shane LG, Fassbender K, et al. Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario. Can J Infect Dis. 2002;13:167–174.
   PubMedGoogle Scholar
• Bergman A, Young C, Maidi-Fargier H, et al. Health care and society have to pay a high price for rotavirus infections in children. A Swedish descriptive cost analysis study. Lakartidningen. 2008;105:1186–1191.
   PubMedGoogle Scholar
• Meeting of the WHO Strategic Advisory Group of Experts on immunization A–car. Position paper rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285–295.
   PubMedGoogle Scholar
• Meeting of the WHO Strategic Advisory Group of Experts on immunization A–car. Position paper rotavirus vaccines. Wkly Epidemiol Rec. 2009;84:220–236.
   PubMedGoogle Scholar
• Parez N, Giaquinto C, Du Roure C, et al. Rotavirus vaccination in Europe: drivers and barriers. Lancet Infect Dis. 2014;14:416–425.
   PubMed Web of Science ®Google Scholar
• Rahmqvist M, Husberg M. Effekter av sjukvårdsrådgivning per telefon: en analys av rådgivningsverksamheten 1177 i Östergötland och Jämtland. CMT Rapport. 2009;3.
   Google Scholar
• 1177 Vårdguiden. Available from: http://www.1177.se/Stockholm/Regler-och-rattigheter/Sjukresor-i-Stockholms-lan
   Google Scholar